Crossmark

Update of the position paper of the Spanish Society of Rheumatology on biosimilar drugs

Crossref DOI link: https://doi.org/10.1016/j.reumae.2019.03.003

Published Print: 2021-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Abad Hernández, Miguel Ángel

Andreu, José Luis

Balsa Criado, Alejandro

Díaz-González, Federico

Moreno Muelas, José Vicente

Queiro Silva, Rubén

Gómez-Reino, Juan J.
License Information

Text and Data Mining valid from 2021-03-01
More Information

This article is maintained by: Elsevier

Article Title: Update of the position paper of the Spanish Society of Rheumatology on biosimilar drugs

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2019.03.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2019.03.007

Content Type: simple-article

Copyright: © 2020 Published by Elsevier España, S.L.U.